Koers Tibet Cheezheng Tibetan Medicine Co., Ltd.
Aandelen
002287
CNE100000FM9
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
22,51 CNY | -0,75% | -0,92% | +0,09% |
Omzet 2022 | 2,04 mld. 282 mln. 264 mln. | Omzet 2023 | 2,05 mld. 282 mln. 264 mln. | Marktkapitalisatie | 11,92 mld. 1,65 mld. 1,54 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 472 mln. 65,14 mln. 60,92 mln. | Nettowinst (verlies) 2023 | 581 mln. 80,18 mln. 74,99 mln. | EV/omzet 2022 | 5,65 x |
Nettoliquiditeiten 2022 | 505 mln. 69,67 mln. 65,16 mln. | Nettoliquiditeiten 2023 | 831 mln. 115 mln. 107 mln. | EV/omzet 2023 | 5,42 x |
K/w-verhouding 2022 |
25,7
x | K/w-verhouding 2023 |
20,5
x | Werknemers | 3.091 |
Dividendrendement 2022 |
1,71% | Dividendrendement 2023 |
2,13% | Vrij verhandelbaar | 10,76% |
1 dag | -0,75% | ||
1 week | -0,92% | ||
Lopende maand | +4,41% | ||
1 maand | +5,48% | ||
3 maanden | +10,72% | ||
6 maanden | -6,52% | ||
Lopend jaar | +0,09% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Mei Yao
DFI | Director of Finance/CFO | 54 | 29-08-18 |
Kai Lie Liu
PSD | President | 60 | 24-01-09 |
Ju Fang Lei
CHM | Chairman | 71 | 08-10-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ju Fang Lei
CHM | Chairman | 71 | 08-10-07 |
De An Guo
BRD | Director/Board Member | 62 | 13-07-22 |
Yu Rong Wang
BRD | Director/Board Member | 48 | 21-12-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 22,51 | -0,75% | 1 955 248 |
25-04-24 | 22,68 | -0,09% | 1 257 095 |
24-04-24 | 22,7 | -0,18% | 1 644 464 |
23-04-24 | 22,74 | +1,88% | 2 385 172 |
22-04-24 | 22,32 | -1,76% | 4 306 960 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+0,09% | 1,65 mld. | |
+35,04% | 5,92 mld. | |
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
-6,82% | 2,42 mld. | |
+47,87% | 1,97 mld. | |
-7,89% | 1,68 mld. | |
-12,97% | 1,53 mld. | |
+33,40% | 1,38 mld. |